Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Krystal Biotech, Inc.    KRYS

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
03/10/2020 | 10:18am EDT

Item 2.02 Results of Operation and Financial Condition.

On March 10, 2020, Krystal Biotech, Inc., a Delaware corporation (the "Company"), announced its fiscal year 2019 financial results. A copy of the Company's press release is attached as Exhibit 99.1 hereto and incorporated by reference herein.

The information concerning financial results in this Form 8-K and in Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information concerning financial results in this Form 8-K and in Exhibit 99.1 shall not be incorporated into any registration statement or other document filed with the Securities and Exchange Commission by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



               Exhibit
                 No.     Description

               99.1        Press Release, dated March 10, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on KRYSTAL BIOTECH, INC.
05/21KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial St..
AQ
05/18Krystal Biotech Announces Pricing of $125 Million Public Offering of Common S..
GL
05/18Krystal Biotech Announces Proposed Public Offering of Common Stock
GL
05/14KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
05/14Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Tr..
GL
05/13KRYSTAL BIOTECH, INC. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
05/05KRYSTAL BIOTECH, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
05/04KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial..
AQ
05/04KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
05/04Krystal Biotech Reports First Quarter 2020 Financial Results and Provides Upd..
GL
More news